Table 1.
Number of diagnostic tests performed at Headquarters and medical status of the total headcount (HC).
| Women | Men | Total | % over total HC | Chi2 p value | ||
|---|---|---|---|---|---|---|
| Headcount (HC) | 4,561 (40.3%) | 6,761 (59.7%) | 11,322 | - | ||
| COVID + | 1,703 (42.3%) | 2,323 (57.7%) | 4,026 | 35.6% | < 0.001 | |
| Employees with COVID medical records | 2,708 (42.0%) | 3,737 (58.0%) | 6,445 | 56.9% | < 0.001 | |
| COVID infections (including reinfections) | 1,762 (42.2%) | 2,418 (57.8%) | 4,180 | - | ||
| qRT-PCR | 3,104 (40.8%) | 4,502 (59.2%) | 7,606 | 67.2% | ||
| qRT-PCR+ | 198 (37.6%) | 329 (62.4%) | 527 | 4.7% | 0.1280 | |
| Antigens | 3,616 (40.7%) | 5,267 (59.3%) | 8,883 | 78.5% | ||
| Antigen+ | 72 (41.4%) | 102 (58.6%) | 174 | 1.5% | 0.9169 | |
| Antibody rapid tests | 3,699 (40.4%) | 5,456 (59.6%) | 9,155 | 80.9% | ||
| IgG+ | 1,169 (41.5%) | 1,649 (58.5%) | 2,818 | 24.9% | 0.1675 | |
| IgM+ | 119 (38.8%) | 188 (61.2%) | 307 | 2.7% | 0.5911 | |
| Quantitative serologies | 129 (43.4%) | 168 (56.6%) | 297 | 2.6% | ||
| IgG+ | 42 (45.2%) | 51 (54.8%) | 93 | 0.8% | 0.7801 | |
| IgM+ | 11 (61.1%) | 7 (38.9%) | 18 | 0.2% | 0.1883 | |
Relative frequencies on each test or status are separated by sex, and relative frequencies over the total headcount. Test results does not include analyses taken externally.